Background Type 2 T-helper cells (Th2) are involved in the regulation of the humoral immune response against antigens and allergens and directly affect which isotype will be produced. The mechanism that regulates antigen-speci®c IgE secretion and immune deviation is still not known. Objectives To delineate mechanisms behind antigen-speci®c IgE secretion we have used in vitro immunization and focused on T-cell phenotype and the activation status of the transcription factor NFkB. Methods Peripheral blood lymphocytes (PBMC) from seronegative donors were immunized in vitro with a peptide consisting of both a T-cell and a B-cell epitope. Results Antigen-speci®c IgE antibodies could be detected after a primary immunization, during which T-helper cells secreted type 2 cytokines. Speci®c IgE was also detected in the secondary immunization, but due to a rapid polarization from Th2 to Th1 phenotype, exogenous IL-4 was required for the speci®c IgE secretion. Analysis of NFkB activation in B and T cells during primary and secondary immunization showed that NFkB could be detected in both B and T cells during primary immunization, but was dependent on exogenous IL-4 in the secondary immunization. Conclusion This is the ®rst evidence of antigen-speci®c IgE induction in vitro using naive B cells, demonstrating the involvement of T-helper cell phenotype and NFkB and demonstrates the usefulness of in vitro cultures to study the effect of antigens on human immunocytes.
Introduction
The speci®c immune response to an antigen is largely dependent on activation of T-helper cells that are able to secrete necessary cytokines [1] . The balance between humoral and cellular immunity is orchestrated by cytokines derived from CD4 T cells (Th), which have been further subdivided into Th1 and Th2 cells [2, 3] . Th1 cells particular secrete IFNg and TNFa/b, which promote in¯ammatory cellular immunity and protect against, e.g. intracellular microorganisms and cancer. Th2 cells, with a lymphokine production skewed towards IL-4 and IL-13, are involved in humoral immunity and the elimination of extracellular pathogens and also in reducing the risk of Th1 cell-mediated autoimmunity [1] . Atopic allergy to normally harmless proteins is correlated to the development of polarized Th2 with high production of type-2 lymphokines, resulting in antigen-speci®c IgE secretion. The immune deviation [4] seen in the neonatal immune response of nonatopics is biased towards Th2 responses, which shifts towards Th1 during the ®rst year of life, while atopic children retain their Th2 response [4] . The mechanisms involved in the development of polarized T helper cells, in particular Th2 cells, as well as of the subsequent antigen-speci®c IgE secretion need further elucidation and prompted us to investigate these questions using an in vitro approach.
In the present study we used the in vitro immunization system, initially designed to induce antigen-speci®c isotype switch from m to g [5] , to also study the induction of speci®c IgE secretion. The switching to e isotype is dependent on lymphokines as well as receptor-mediated signals and it has recently been shown that ligation of CD40 by CD40L, in the presence of soluble IL-4, leads to activation of the transcription factor NFkB. This factor binds to the e-promoter inducing transcription of the unrearranged constant region gene [6±9] . This transcription facilitates recombination of the variable-region gene 5 H of the expressed IgE constant-region, which will ultimately lead to expression of mature IgE antibodies. CD40 is thus a central player in regulating IgE production. The importance of NFkB in mediating the effects of CD40 ligation is emphasized by a study, which shows that NFkB knockout mice have defects in isotype switching [10] . In addition to its direct role in B cells, NFkB may also have an indirect in¯uence on isotype switching by its effects in T cells [11] . The basis of the present in vitro immunization system is a cognate interaction between T and B cells, supported by the use of a heterotope peptide containing a T-helper cell recall epitope and the speci®c B-cell antigen epitope. The speci®c B-cell response is driven by antigen activated T cells and recognition of the B-cell epitope by surface immunoglobulin [12] . We have studied the antigen-speci®c induction of IgE, using a similar approach, including phenotypic analysis of Th cells during both the primary and secondary in vitro immunization [13] . The activation status of NFkB in both T cells and B cells was also probed after different stimulation periods to correlate the activation of NFkB with progression of T-cell differentiation and isotype switching.
Materials and methods

Antibodies, antigens and cytokines
FITC-labelled anti-CD19, anti-CD14 and anti-CD16 antibodies and the R-phycoerythrin (RPE)-labelled anti-CD3 antibody were obtained from Dako A/S (Glostrup, Denmark). Anti-CD3 FITC was purchased from Becton Dickinson Inc. (San Jose, CA, USA). Anti-CD4 tricolour (TC), was purchased from Caltag (San Francisco, CA, USA). Anti-IL-4-RPE and anti-IFNg-RPE were purchased from Pharmingen (San Diego, CA, USA). The S2C6 anti-CD40 mAb was a generous gift from Dr Staffan Paulie (Stockholm University, Sweden). Peptide antigens pTT, pV3 and pTT-pV3 were kindly provided by Dr Elias Krambovitis (Institute of Molecular Biology and Biotechnology, Greece). The peptides are shown in Table 1 . pB1, a recombinant protein containing most of the C-terminal part of the gp120 (HIV-1) was a generous gift from Repligen Inc. Tetanus toxoid (TT) was purchased from the Swedish Institute for Infectious Disease Control (Stockholm, Sweden). IL-4 was obtained from Genzyme (Cambridge, MA, USA).
Cells and medium
Buffy coats were obtained from healthy, HIV-1 seronegative donors from the University Hospital Blood Bank (Lund, Sweden). All sera were initially tested in ELISA for antibodies against TT. Peripheral blood mononuclear cells (PBMC) from TT-positive donors were isolated as described previously [13] . Brie¯y, PBMC were separated from red blood cells on Ficoll-Paque (Pharmacia, Uppsala, Sweden) by density centrifugation. The isolated PBMC were incubated in RPMI 1640, containing 2% human serum, together with freshly prepared 0.175 mM L-leucyl- 
Primary in vitro immunization
3´10
6 LLOMe-treated cells were cultured for 7 days in medium containing 10% human serum, 50 mM 2-mercaptoethanol, 40 ng IL-2/mL, 25% T-cell replacing factor (TRF) [5±13] . The cells were immunized with 7 nM pTT-pV3 peptide.
Generation of activated T-helper cells for the secondary immunization
T cells in the LLOMe treated cell population were activated by culturing 1´10 6 cells/mL together with 1´10 6 /mL feeder cells (irradiated autologous PBMC) in tissue culturē asks with 50 mM 2-mercaptoethanol and 10 mM pTT for 7 days [12] . At day 3, fresh complete culture medium was added to the cultures.
Secondary in vitro immunization
Primary immunized cells as well as the activated T cells were harvested and centrifuged through 40% Ficoll-Paque, at day 7. After one wash, the proportion of B and T cell was determined by FACS analysis. 0.5´10 6 /mL cells from the primary immunization were cocultured together with 0.2´10 6/ mL T cells from the antigen-speci®c T-cell activation on a monolayer of irradiated CD32-transfected ®broblasts for a secondary immunization period. The cells were cultured for 4 days in medium, supplemented with 5% human serum, 50 mM 2-mercaptoethanol, 7 nM pTT-pV3 and 0.5 mg/mL anti-CD40 antibody, with and without the supplementation of 100 U IL-4/mL.
A population of primary and secondary immunized cells were infected with EBV, as described previously [14] , and cultured for 10±20 days in presence of irradiated feeder cells in medium containing fetal calf serum. The culture supernatant was then removed and analysed for total as well as antigen-speci®c human IgE antibodies.
Intracellular staining
T cells were analysed for intracellular cytokines, as described previously [15] . Cells from primary and secondary immunization were treated with 20 ng/mL PMA and 16 mM/L ionomycin (Sigma-Aldrich Chemie, Germany) over night. Two hours before harvesting the cells, Brefeldin A 5 mg/mL (Sigma-Aldrich Chemie) was added. The cells were washed with PBS supplemented with 1% BSA and stained with anti-CD3 FITC. The cells were washed twice and ®xed with 2% formaldehyde for 15 min and then permeabilized after a wash, with 0.5% Tween for 45 min. The cells were then incubated with anti-IL-4 or anti-IFNg antibodies. After a 30-min incubation in the dark, the cells were washed and analysed by¯ow cytometry, using a FACScan (Beckton Dickinson Inc.).
Preparation of nuclear fractions for NFkB analysis
B and T cells from primary and secondary cultures were separated with anti-CD19 and anti-CD3 magnetic beads (Dynal A.S., Oslo, Norway), respectively. After separation, 0.5±1´10 6 cells were centrifuged at 1500 g for 5 min and the cells resuspended in 1 mL hypotonic buffer (10 mM HEPES-NaOH buffer, pH 7.9, containing 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol and 0.5 mM PMSF). Cells were pelleted by centrifugation at 14000 g for 10 min and then lysed for 10 min on ice in hypotonic buffer (20 mL), containing 0.1% (v/v) Nonidet P-40. Lysates were centrifuged at 14000 g for 10 min. The resulting pellets were resuspended in 20 mM HEPESNaOH buffer, pH 7.9 (15 mL), containing 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% (w/v) glycerol and 0.5 mM PMSF and incubated for 15 min on ice. The nuclear suspensions were then centrifuged at 14000 g for 10 min and the supernatants were transferred into 10 mM HEPES/NaOH buffer, pH 7.9 (75 mL), containing 50 mM KCl, 0.2 mM EDTA, 20% (w/v) glycerol, 0.5 mM PMSF and 0.5 mM dithiothreitol. Such samples constituted of nuclear extracts. Protein concentrations of nuclear extracts were determined [16] and the extracts assayed immediately for NFkB activity or stored at À 70 8C until further use. All of the steps in the above procedure were performed at 4 8C, unless otherwise stated.
Electrophoretic mobility shift assay
Nuclear extracts (4 mg protein) were incubated with 20 000 c.p.m. of a 22-bp oligonucleotide containing the NFkB consensus sequence, which had been previously labelled with [g-32 P]ATP (10 mCi/mmol) by T4 polynucleotide kinase [17] . Incubations were performed for 30 min at room temperature in the presence of 2 mg poly (dI-dC) and 10 mM Tris-HCl buffer, pH 7.5, containing 100 mM NaCl, 1 mM EDTA, 5 mM dithiothreitol, 4% (w/v) glycerol and 0.1 mg/mL nuclease-free BSA. All incubations were subjected to electrophoresis on 4% (w/v) polyacrylamide gels, which were subsequently dried and autoradiographed.
Detection of antigen-speci®c antibodies with ELISA
ELISA was performed by coating microtitre plates (Life Technologies, Sweden) with 70 ng pB1/well or 1 mg bovine serum albumin/well or 0.05 mg rabbit antihuman IgE/well (Dako A/S Glostrup, Denmark) in sodium carbonate buffer, Detection of TT antibodies in sera was performed as described previously [12] .
Results
Induction of antigen-speci®c IgE by in vitro immunization
A schematic representation of the in vitro immunization system used in this study is outlined in Fig. 1 . During the primary stimulation period (day 1±7) B cells receive signals from the antigen, T cells and exogenously added lymphokines, mainly IL-2 [5] , whereas the secondary period (day 8±11) provided signals by the antigen, antigen-speci®cally activated T cells and CD40 ligation. The result of this stimulation was analysed as the frequency of B cells producing antigen-speci®c IgE as well as total IgE and is shown in Table 2 . Antigen-speci®c IgE antibodies could be detected after both primary and secondary immunization, where the frequency of B cells producing speci®c antibodies varied between individual donors. The frequency of antigen-speci®c B cell clones decreased, however, signi®cantly during the secondary stimulation period. This could be reversed when IL-4 was allowed to be present during day 8±11 and then the mean frequency of B cells secreting antigen-speci®c IgE increased > 10 times, demonstrating that the switch to an e isotype was IL-4 dependent in vitro.
The reactivity index (RI) of antigen-speci®c IgE antibodies produced by the in vitro immunization was also determined. The RI-values correlate to the amount of IgE detected in vitro and/or to the antibody af®nity of the secreted IgE. The responses were in general very strong with several clones exhibiting RI > 50 (Table 3) .
Rapid Th1 polarization occurs during the secondary immunization period
To investigate why the secondary immunization was dependent on exogenously added IL-4 we monitored the Th phenotype during the different stimulation periods. Cells were stained for CD3, ®xed and analysed for intracellular cytokines. Thirty to 50% of T cells from primary immunized cultures (day 7) were positive for intracellular IL-4 but < 5% of the CD3 T cells produced IFNg (Fig. 2) , indicating that the major phenotype was Th2. The separately generated antigen-speci®c Th cells had also a Th2 cytokine pro®le at the initiation of the secondary immunization, which was comparable to the Th cells present during the primary immunization period. Cells were then harvested after the secondary immunization period (day 11) and the cytokine pro®le was analysed. At this time point, i.e. 11 days after initiation, > 60% of the Th cells in the cultures were now IFNg positive, whereas less than 2% were positive for intracellular IL-4 (Fig. 2) . This very rapid polarization of cytokine pro®le occurred over only 4 days and was independently of exogenously added IL-4 to the secondary cultures, i.e. the majority of Th cells was of Th1 phenotype even if 100 U IL-4 had been present. Further attempts were also made to inhibit the Th polarization by modulating some of the other signalling pathways possibly involved in the observed immune deviation during the secondary immunization period. Therefore, the polarization was analysed after, (i) removal of the CD40 signalling and (ii) addition of blocking anti-IL-12 antibodies (50 mg/mL). The polarization from a Th2 to a Th1 phenotype was, however, unaffected by these attempts (data not shown).
Activation of NFkB in T and B cells is dependent on IL-4
To further study the effect of IL-4 on signalling pathways, during the in vitro induction of antigen-speci®c IgE, we analysed the presence of NFkB a transcription factor known to be involved in the inducible transcription of a variety of genes, including the e isotype and IL-2, a Th1-type cytokine. Nuclear extracts from T cells which had been subjected to primary immunization showed detectable levels of NFkB, as determined by electrophoretic mobility shift assay. These levels of NFkB were independent of exogenously added IL-4. However, during the secondary in vitro immunization IL-4 promoted an increased activation of NFkB in Th cells. Interestingly, this activation was characterized by increased levels of one speci®c DNA-protein complex of highest electrophoretic mobility, indicating the ability of IL-4 to differentially induce one of the DNA-protein complexes (Fig. 3) . Similarly, nuclear extracts from primary immunized naive B cells showed high levels of activated NFkB, where the normal presence of several DNA-protein complexes are evident (Fig. 3) . The levels were again independent of IL-4 during the primary immunization period. However, the levels of NFkB in nuclear extracts from B cells following secondary immunization were highly dependent on IL-4. The presence of IL-4 during secondary immunization induced B cells with signi®cantly higher levels of NFkB, relative to cells derived from an immunization protocol where IL-4 was absent. This lends further support to the observation of increased frequency of B cell clones secreting IgE in the presence of IL-4 ( Table 2 ).
Discussion
The induction of IgE in human B cells is mediated by a cognate interaction with Th2 helper cells. These T cells deliver signals by ligating the CD40 molecule on B cells and by secreting IL-4, the latter being a crucial signal for isotype switching to IgE [9] . Other signals that have been implicated to play a role in the regulation of IgE production are, e.g. CD21/CD23 interaction, IFNg, LFA-1/ICAM±1 interaction, as well as the nature of the antigen itself [18±21]. The mechanisms behind isotype switching and IgE secretion have been extensively studied, although the focus predominantly has been on total IgE secretion and very little data exists on antigen-speci®c IgE induction. In particularly, dissection of this response in vitro needs to be performed, since any differential mechanisms behind antigen and allergen could be elucidated in a more controlled environment. It was, e.g. recently demonstrated that CD2 stimulated T cells together with CD40 and allergen stimulated B cells induce speci®c IgE production in an IL-4 dependent manner [22] . This speci®c IgE production was dependent on a low dose of allergen and optimal T-cell stimulation, indicating a delicate control of speci®c IgE synthesis. The in vitro system used in the present investigation is based on antigen activation of both T and B cells, using a recall antigenic epitope for T-cell activation, and has previously been shown to induce antigen-speci®c isotype switch from m to g [5, 12, 13] . The earlier studies focused on dissecting the signalling mechanism required for isotype switching from m to g, whereas in the present investigation we have studied the T-cell phenotype, transcription factor activation and effect of cytokines known to affect isotype switching to e. In this study, we could detect antigenspeci®c IgE antibodies after both primary and secondary immunization periods, where the frequency of B cells producing speci®c IgE varied between individual donors, as also was observed previously [5] . This indicates that the cells can undergo immunoglobulin class switching within 7 days of culture, since the presence of preswitched IgE B-cells speci®c for the V3-peptide in seronegative donors is unlikely. Interestingly, we see after the secondary immunization period (day 8±11) that the ratio of B cells secreting antigen-speci®c IgE compared to total IgE increased, indicating an antigen-driven IgE induction. The RI values for the speci®c IgE antibody responses were generally very strong with clones showing RI > 50, which is considerably higher compared with RI-index for antigen-speci®c IgG antibodies induced by in vitro immunization, as previously reported [5, 12] . Furthermore, the frequency of B-cell clones secreting detectable levels of antigen-speci®c IgE was > 10 times higher when soluble IL-4 was present during the secondary culture period. Exogeneously added IL-4 also substantially increased the intracellular levels of NFkB, which is known to be directly involved in the transcription of e isotypes. The reason that the secondary stimulation period required addition of IL-4 to support any signi®cant antigen-speci®c IgE secretion was most probably due to the rapid T-helper cell polarization from Th2 to Th1 that was observed. This is also supported by the fact that the level of IgE synthesis is proportional to the number of Th2 cells added to B cells and the help of Th1 cells is limited by their cytolytic capacity [23] .
The phenotype of the T-helper cells was monitored during the culture period, since the subtype of helper cell is crucial to the induction of a humoral immune response in vitro. We found that after the primary immunization the majority of the T cells were of a Th2 phenotype but after an additional 4 day culture period, together with antigenstimulated Th2 cells and anti-CD40 antibodies, the Th cells exhibited a rapid polarization and initiated a secretion of IFNg, a Th1 cytokine. Addition of exogenous IL-4 during the secondary immunization could not reverse this differentiation towards a Th1 phenotype. It is also well established that IL-12 induces IFNg production in T cells and promotes a Th1 cytokine pro®le [24] . Therefore, we added a blocking anti-IL-12 antibody to the secondary culture in an attempt to prevent the rapid Th1 polarization. Also CD40 signalling of B cells has been shown to induce IL-12 production in human B cells. Addition of anti-IL-12 antibodies as well as removing the anti-CD40 antibodies and the ®broblasts from the secondary cultures failed to prevent the Th2 to Th1 polarization. One possible explanation, presently under investigation, is that the`default mode' of T-helper cells is Th1, which is indicated by the rapid in vitro polarization. The immune deviation we see in our culture system is similar in concept to what Holt and Macaubas discussed for the in vivo situation in a recent review [25] . They suggested that during infancy, low levels of environmental allergens pass the placenta barrier and together with Th1 inhibitory factors generate T-helper cells skewed towards Th2. An immune deviation after birth will then result in a Th1-skewed memory. It was also recently demonstrated that the Th2-skewed response to common environmental allergens was present in all new born infants suggesting that the key aetiological factor in atopic disease may not be the initial allergenspeci®c Th2-skewed immunity but rather the ef®ciency of the underlying mechanisms responsible for the immune deviation [26] . When NFkB activation was analysed in both T and B cells it was clear that NFkB was present in the cells during the primary immunization and addition of IL-4 to those cultures did not seem to enhance the expression. In contrast, addition of IL-4-promoted enhanced NFkB activation in both B and T cells during the secondary immunization. These observations were also supported by Iciek and coworkers [7] who showed that CD40 cross-linking induced e transcripts via activation of NFkB in synergy with IL-4. Thus it seems as if the T cells in the present assay, during primary immunization, have the proper phenotype to provide B cells with suf®cient CD40 stimulation and cytokines to activate NFkB, which then promotes IgE switching. However, the T cells rapidly acquired a Th1 phenotype during secondary immunization, which results in the lack of NFkB in B and T cells during the secondary immunization in cultures not supplemented with IL-4.
In summary, we show that the Th1/Th2 ratio play a fundamental role in the regulation of antigen-speci®c IgE synthesis in vitro. Furthermore, the data indicate an antigendriven stimulation of the speci®c B cells, where the speci®c IgE secretion was increased by IL-4. In vitro studies might thus play a role when dissecting mechanisms underlying antigen-speci®c IgE induction and immune deviation. 
